GI
AZN icon

GAMMA Investing’s AstraZeneca AZN Stock Holding History

GAMMA Investing’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Sell
7,491
-147
-2% -$27.6K 0.05% 297
2026
Q1 		$1.51M Buy
7,638
+997
+15% +$192K 0.07% 242
2025
Q4 		$1.22M Buy
6,641
+1,023
+18% +$179K 0.06% 250
2025
Q3 		$862K Buy
5,618
+1,156
+26% +$175K 0.05% 335
2025
Q2 		$624K Buy
4,462
+523
+13% +$73.3K 0.04% 405
2025
Q1 		$579K Buy
3,939
+1,190
+43% +$172K 0.04% 369
2024
Q4 		$360K Buy
2,749
+32
+1% +$4.48K 0.03% 476
2024
Q3 		$423K Buy
2,717
+444
+20% +$71.7K 0.04% 376
2024
Q2 		$355K Buy
2,273
+493
+28% +$74.2K 0.05% 343
2024
Q1 		$241K Buy
1,780
+310
+21% +$41K 0.05% 340
2023
Q4 		$196K Buy
+1,470
New +$191K 0.05% 309

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GAMMA Investing's AZN Position: Q2 2026 in Review

GAMMA Investing reduced its AstraZeneca (AZN) stake by 1.9% in Q2 2026, selling an estimated $27.6K and leaving 7,491 shares worth $1.42M. The position accounts for 0.05% of the portfolio, ranked #297.

GAMMA Investing first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.51M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • GAMMA Investing held 7,491 shares of AstraZeneca worth $1.42M as of Q2 2026.
  • GAMMA Investing sold 147 AstraZeneca shares in Q2 2026, an estimated $27.6K.
  • AstraZeneca made up 0.05% of GAMMA Investing's portfolio in Q2 2026, its #297 holding.
  • GAMMA Investing first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's AstraZeneca position peaked at $1.51M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.